RxDoctor Payments Data

Manish Mehta, MD

Hand Surgery · Boston, MANPI 1811491566

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,982 of the $6,082 with a category attached, or 65.5%. 15 manufacturers reported payments, led by Arthrex at 24.4% of the total. Reporting peaked in 2024 at $2,316 and has fallen 81.1% since, to $438 in 2025.

$6,082in general payments, 2019–2025

Across 68 payments — averaging $89.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$1K
  • Axogen$1K
  • Skeletal Dynamics Inc$841
  • Stryker$805
  • Johnson & Johnson$614
  • Medical Device Business Services, Inc.$400
  • plus $870 from 9 others

What the payments were for

  • Travel & lodging$1,70128%
  • Food & beverage$3,98265%
  • Education$4007%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,082 in reported general payments places this provider in the 65th percentile of 68 hand surgery providers in Massachusetts.

See all hand surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$5,403
Medicare patients
20
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl33$77

Paid to pharmacies, not to this prescriber.

Other hand surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →